Exicure

XCURNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.248 M

$1.26 +2.44%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$4.95M

Loss-making

Shares outstanding

6,373,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#438BullFrog AIBFRG$9.14M
#439FibroBiologicsFBLG$9.06M
#440ExicureXCUR$8.25M
#441Ensysce BiosciencesENSC$8.19M
#442SoligenixSNGX$8.10M

What if Exicure were worth as much as…

Open the what-if tool →

Gold $30.3T

$4,624,821

Per share 3,670,493× higher

Bitcoin $1.72T

$262,726.09

Per share 208,513× higher

Nvidia $5.48T

$837,131.38

Per share 664,390× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Exicure are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.